Coronavirus disease 2019 (COVID-19) emergency use authorizations (EUAs)

Coronavirus disease 2019 (COVID-19) emergency use authorizations (EUAs)

Detalles Bibliográficos
Autor principal: United States Food and Drug Administration (author)
Autor Corporativo: United States Food and Drug Administration, author, issuing body (author)
Formato: Seriada digital
Idioma:Inglés
Publicado: Silver Spring, MD : Food and Drug Administration 2021.
Materias:
COVID-19 (Disease)
COVID-19 drug therapy.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820258206719
Tabla de Contenidos:
  • Vaccines
  • Last Update: June 15, 2023.
  • COVID-19 Vaccines
  • Convalescent Plasma
  • Novavax Decision Memorandum - July 13, 2022 - References
  • Novavax Decision Memorandum - October 19, 2022 - References
  • Janssen Decision Memorandum - February 4, 2021 - References
  • Janseen - Memorandum to the file - October 4, 2021 - References
  • Moderna Decision Memorandum - November 30, 2020 - References
  • Moderna Review Memorandum - September 3, 2021 - References
  • Moderna Decision Memorandum - October 20, 2021 - References
  • Moderna Decision Memorandum - June 17, 2022 - References
  • Moderna Decision Memorandum - August 31, 2022 - References
  • Moderna Decision Memorandum - April 18, 2023 - References
  • Pfizer Decision Memorandum - December 2020 - References
  • Pfizer Decision Memorandum - May 2021 - References
  • Pfizer Decision Memorandum - September 24, 2021 - References
  • Pfizer Decision Memorandum - October 29, 2021 - References
  • Pfizer Decision Memorandum - May 17, 2022 - References
  • Pfizer Decision Memorandum - June 17, 2022 - References
  • Pfizer Decision Memorandum - August 31, 2022 - References
  • Pfizer Decision Memorandum - October 2022 - References
  • Pfizer Decision Memorandum - December 2022 - References
  • Pfizer Decision Memorandum - March 2023 - References
  • Pfizer Decision Memorandum - April 18, 2023 - References
  • Emergency Use Authorization (EUA) Amendment for an Unapproved Product Review Memorandum References
  • Drug and Biological Therapeutic Products
  • Last Update: April 10, 2024.
  • EUAs for CDER-regulated Products
  • COVID-19 Convalescent Plasma Clinical Memorandum December 27, 2021 - References
  • COVID-19 convalescent plasma Decision Memorandum References
  • Medical Devices
  • Last Update: April 15, 2024.
  • Blood Purification Devices EUAs
  • Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs
  • In Vitro Diagnostics EUAs
  • Infusion Pump EUAs
  • Personal Protective Equipment EUAs
  • Withdrawal Due to Other Reasons
  • Remote or Wearable Patient Monitoring Devices EUAs
  • Respiratory Assist Devices EUAs
  • Ventilators and Ventilator Accessories EUAs
  • Other Medical Device EUAs.

Ejemplares similares